Presentation TCT 2017 CMS Perspectives on Post-Approval Device Evaluation(Including NEST) and Reimbursement Presenter: Daniel A Canos October 30, 2017 REGISTER for free or LOG IN to view this content Policy & Practice Presentation TCT 2017 Guidelines Up Next Presentation TCT 2017 How to Interpret Noninferiority Trials (eg, ABSORB III, EVEREST II, and Others) Presenter: Sanjay Kaul October 30, 2017 More slides + Presentation TCT 2017 How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others) Presenter: Laura Mauri October 30, 2017 Presentation TCT 2017 Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others) Presenter: Stuart J. Pocock October 30, 2017 We Recommend
Presentation TCT 2017 How to Interpret Noninferiority Trials (eg, ABSORB III, EVEREST II, and Others) Presenter: Sanjay Kaul October 30, 2017
Presentation TCT 2017 How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others) Presenter: Laura Mauri October 30, 2017
Presentation TCT 2017 Strengths and Limitations of Composite Endpoints (eg, EXCEL, PLATO, and Others) Presenter: Stuart J. Pocock October 30, 2017